News Releases

NCPA Members List Top 2018 Policy Priorities

by NCPA | Feb 05, 2018

ALEXANDRIA, Va. (Feb. 5, 2018) — For the second year in a row, retroactive pharmacy direct and indirect remuneration fees rank as the top legislative and regulatory priority for members of the National Community Pharmacists Association. More than 37 percent of respondents chose DIR fees as the top concern. This is the fifth year in a row for the annual survey, which enables NCPA's Advocacy Center to craft an agenda based on member feedback.

"Independent community pharmacists have made it abundantly clear in their responses to NCPA's survey that relief from retroactive pharmacy DIR fees is their top priority," said NCPA CEO B. Douglas Hoey, Pharmacist, MBA. "The resulting problems for pharmacies and patients is something NCPA has shared with the Centers for Medicare & Medicaid Services. Subsequently, in its 2019 proposed rule, CMS solicited comments on a proposal to put all price concessions at the point of sale. In addition to regulatory progress, NCPA is pushing for federal legislation with the same solution: S. 413 / H.R. 1038, the Improving Transparency and Accuracy in Medicare Part D Drug Spending Act."

The other top priorities in the NCPA priorities survey include:

  • 16.2 percent of respondents identified generic prescription drug transparency to address delays in payment rates and appeals processes as their top priority, which can be fixed by passing H.R. 1316, the Prescription Drug Price Transparency Act.

  • 14.2 percent of respondents listed fair and reasonable Medicaid reimbursement to pharmacy as their No. 1 priority, which falls under the purview of states.

  • 13.6 percent of respondents said being included in preferred pharmacy networks was most important, which can be addressed by enacting S. 1044 / H.R. 1939, the Ensuring Seniors Access to Local Pharmacies Act.

"Creating greater generic prescription drug transparency in federal health programs and participating in Medicare Part D preferred pharmacy networks continues to concern NCPA's members," said Hoey. "However, a new issue has emerged in the last year. Medicaid managed care reimbursements are simply too low. That is why NCPA is working with our state partners to address this problem."


The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 22,000 independent community pharmacies. Together they represent an $80 billion health care marketplace and employ more than 250,000 individuals on a full- or part-time basis. To learn more, go to, visit, or follow NCPA on Twitter @Commpharmacy.